Earnings Feed
Start Free
Home/Insiders/Rickard Kathleen A.
RK
SEC Insider//CIK 0001836883

Rickard Kathleen A.

CIK 00018368831 companyLONDON, X0
SEC Profile

Transactions

50

Companies

1

Filings

5

CIK

0001836883

Recent Transactions

50 trades
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−146,168→ 0 total
  • Disposition to Issuer
    Verona Pharma plc$VRNA

    Share Options (Right to Buy)

    2025-10-07−100,000→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−200,000→ 0 total
  • Award
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07+618,760→ 618,760 total
  • Disposition to Issuer
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-10-07−1,131,984→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-10-07+1,131,984→ 1,131,984 total
  • Disposition to Issuer
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-10-07−2,432,868→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−167,056→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−618,760→ 0 total
  • Disposition to Issuer
    Verona Pharma plc$VRNA

    Share Options (Right to Buy)

    2025-10-07−560,000→ 0 total
  • Gift
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-08-29−189,600→ 2,417,872 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Stock Units

    2025-08-01−20,888→ 146,168 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-08-01+70,888→ 2,665,808 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-08-01$13.14/sh−58,336→ 2,607,472 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Stock Units

    2025-08-01−50,000→ 200,000 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-07-08$11.44/sh−37,616→ 2,594,920 total
  • Award
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-07-07+253,120→ 253,120 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-07-07+86,064→ 2,632,536 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-07-07−86,064→ 167,056 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-06$8.82/sh−114,984→ 2,546,472 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-05-01−50,000→ 250,000 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-01$8.95/sh−21,864→ 2,661,456 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-01+50,000→ 2,683,320 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-01$8.95/sh−27,336→ 2,633,320 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-04-29−86,064→ 167,056 total
  • Award
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-04-29+253,120→ 253,120 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-04-29+86,064→ 2,695,040 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-04-29$8.98/sh−34,384→ 2,660,656 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-03-12$8.35/sh−79,264→ 2,608,976 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-02-03$7.16/sh−33,240→ 2,688,240 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-02-01+50,000→ 2,721,480 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-25$4.90/sh−240,000→ 2,671,480 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-01$4.24/sh−65,936→ 2,911,480 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-01+50,000→ 2,977,416 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-10-30+300,000→ 2,927,416 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-08-07+200,000→ 2,715,320 total
  • Award
    Verona Pharma plc$VRNA

    Restricted Share Units

    2024-08-07+300,000→ 300,000 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-08-07$2.62/sh−87,904→ 2,627,416 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-08-01$2.83/sh−106,232→ 2,515,320 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-05-03$1.96/sh−36,248→ 2,621,552 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-05-01$1.93/sh−73,824→ 2,657,800 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-02-05$2.22/sh−36,248→ 2,731,624 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-02-01$2.29/sh−72,768→ 2,767,872 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2023-11-03$1.92/sh−58,752→ 2,840,640 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2023-11-01$1.74/sh−173,136→ 2,899,392 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2023-10-20+200,000→ 3,072,528 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2023-08-07$2.47/sh−1,600→ 2,872,528 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2023-08-04$2.50/sh−27,944→ 2,874,128 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2023-08-03$2.55/sh−28,752→ 2,923,920 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2023-08-03$2.54/sh−21,848→ 2,902,072 total

Companies

1

Recent Filings

5

Address

3 MORE LONDON RIVERSIDE

LONDON, X0, SE1 2RE

View on SEC.gov